← Leaderboards
Raymond J Dingledine
Emory University
$29,610,268
Attributed
$32,993,735
Total exposure
21
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.5M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$43,548,626 · 23
By mechanism
U54$19,248,206 · 2
R01$12,856,856 · 7
U01$6,163,689 · 2
P30$1,385,000 · 1
UG3$1,152,900 · 2
S10$976,945 · 5
Top collaborators
- Avtar S Roopra5 shared
- Jenny Hsieh4 shared
- Thota Ganesh3 shared
- Nicholas Varvel2 shared
Most similar at Emory University
Same institution · by research overlap
- Nicholas Varvel$2,686,741
- Stefan G Sarafianos$26,943,765
Others in their field
Top investigators on “Status Epilepticus”
- Shlomo Shinnar · Montefiore Medical Center (Bronx, Ny)$32,949,853
- William G Barsan · University Of Michigan At Ann Arbor$26,202,515
- Jaideep Kapur · University Of Virginia$19,695,738
- Douglas A Coulter · Children'S Hospital Of Philadelphia$16,838,194
- James O. McNamara · Duke University$15,569,148
- Robert Delorenzo · Virginia Commonwealth University$13,540,181
Research focus
Status EpilepticusSeizuresBrainNeuronsCognitive DeficitsInflammationRodentEventSeriesReactionNerve DegenerationPilocarpineReceptorCyclooxygenase 2Brain InjuriesDinoprostonePathway InteractionsKainateMolecularSmall MoleculeEpilepsyGenesHippocampus (Brain)Mediating
Grant awards (71)
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits$679,487
UH3 · FY2023 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively$520,230
R01 · FY2023 · NS · contact PI
Probing the Protective Role of EZH2 in Epilepsy$507,003
R01 · FY2023 · NS
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits$677,532
UG3 · FY2022 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively$520,230
R01 · FY2022 · NS · contact PI
Probing the Protective Role of EZH2 in Epilepsy$507,003
R01 · FY2022 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively$520,230
R01 · FY2021 · NS · contact PI
Probing the Protective Role of EZH2 in Epilepsy$507,003
R01 · FY2021 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively$520,230
R01 · FY2020 · NS · contact PI
Probing the Protective Role of EZH2 in Epilepsy$504,791
R01 · FY2020 · NS
EP2 Antagonist Development for Post-seizure Cognitive Deficits$475,368
UG3 · FY2020 · NS · contact PI
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures$422,180
R01 · FY2020 · NS · contact PI
Probing the Protective Role of EZH2 in Epilepsy$511,803
R01 · FY2019 · NS
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures$422,180
R01 · FY2019 · NS · contact PI
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures$422,180
R01 · FY2018 · NS · contact PI
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures$427,465
R01 · FY2017 · NS · contact PI
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures$444,453
R01 · FY2016 · NS · contact PI
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures$68,796
R01 · FY2016 · NS · contact PI
Prostanoid Modulators that Reduce Brain Injury After Seizures$527,623
U01 · FY2015 · NS · contact PI
Prostanoid Modulators that Reduce Brain Injury After Seizures$527,623
U01 · FY2014 · NS · contact PI
Regulation of epileptogenesis by the transcriptional repressor REST$336,538
R01 · FY2014 · NS · contact PI
Prostanoid Modulators that Reduce Brain Injury After Seizures$527,623
U01 · FY2013 · NS · contact PI
Regulation of epileptogenesis by the transcriptional repressor, REST$328,040
R01 · FY2013 · NS · contact PI
Prostanoid Modulators that Reduce Brain Injury After Seizures$527,623
U01 · FY2012 · NS · contact PI
Regulation of epileptogenesis by the transcriptional repressor, REST$339,938
R01 · FY2012 · NS · contact PI
Role of COX2 of Neuronal Origin in Blood-Brain Communication after status epilept$193,750
R21 · FY2012 · NS · contact PI
EP2 Allosteric Potentiators for Subarachnoid Hemorrhage$31,873
U01 · FY2012 · NS · contact PI
Prostanoid Modulators that Reduce Brain Injury After Seizures$561,790
U01 · FY2011 · NS · contact PI
Regulation of epileptogenesis by the transcriptional repressor, REST$351,969
R01 · FY2011 · NS · contact PI
Role of COX2 of Neuronal Origin in Blood-Brain Communication after status epilept$232,500
R21 · FY2011 · NS · contact PI
EP2 Allosteric Potentiators for Subarachnoid Hemorrhage$193,750
U01 · FY2011 · NS · contact PI
Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease$747,500
P30 · FY2010 · NS · contact PI
Prostanoid modulators that reduce brain injury and inflammation after seizures$681,405
U01 · FY2010 · NS · contact PI
Prostanoid modulators that reduce brain injury and inflammation after seizures$666,225
U01 · FY2009 · NS · contact PI
Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease$637,500
P30 · FY2009 · NS · contact PI
Emory Chemistry-Biology Center in the MLSCN$757,175
U54 · FY2008 · HG · contact PI
Prostanoid modulators that reduce brain injury and inflammation after seizures$651,488
U01 · FY2008 · NS · contact PI
Genetic Control of Glutamate Receptor Function$335,479
R01 · FY2008 · NS · contact PI
Prostanoid modulators that reduce brain injury and inflammation after seizures$41,876
U01 · FY2008 · NS · contact PI
EMORY CHEMISTRY-BIOLOGY CENTER IN THE MLSCN(RMI)$4,272,029
U54 · FY2007 · HG · contact PI
Emory Chemistry-Biology Center in the MLSCN(RMI)$4,088,558
U54 · FY2007 · HG · contact PI
Prostanoid modulators that reduce brain injury and inflammation after seizures$611,633
U01 · FY2007 · NS · contact PI
Genetic Control of Glutamate Receptor Function$335,479
R01 · FY2007 · NS · contact PI
Emory Chemistry-Biology Center in the MLSCN$183,471
U54 · FY2007 · HG · contact PI
Emory Chemistry-Biology Center in the MLSCN$3,067,051
U54 · FY2006 · HG · contact PI
EMORY CHEMISTRY-BIOLOGY CENTER IN THE MLSCN(RMI)$2,820,051
U54 · FY2006 · HG · contact PI
Prostanoid modulators that reduce brain injury and inflammation after seizures$613,157
U01 · FY2006 · NS · contact PI
Genetic Control of Glutamate Receptor Function$345,498
R01 · FY2006 · NS · contact PI
Emory Chemistry-Biology Center in the MLSCN(RMI)$2,029,936
U54 · FY2005 · HG
EMORY CHEMISTRY-BIOLOGY CENTER IN THE MLSCN(RMI)$2,029,935
U54 · FY2005 · HG
Genetic Control of Glutamate Receptor Function$353,813
R01 · FY2005 · NS
High content cell-based assay system$428,700
S10 · FY2004 · RR
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTION$354,960
R01 · FY2004 · NS
HIGH CONTENT CELL-BASED ASSAY SYSTEM: NERVOUS SYSTEM, RETINA STUDIES$142,902
S10 · FY2004 · RR
HIGH CONTENT CELL-BASED ASSAY SYSTEM: PHARMACOLOGY$142,899
S10 · FY2004 · RR
HIGH CONTENT CELL-BASED ASSAY SYSTEM: HUNTINGTON'S DISEASE$142,899
S10 · FY2004 · RR
MODULATION OF KAINATE RECEPTORS$340,960
R01 · FY2003 · NS
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTION$320,402
R01 · FY2003 · NS
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTION$25,000
R01 · FY2003 · NS
FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPES$342,000
R01 · FY2002 · NS
MODULATION OF KAINATE RECEPTORS$340,960
R01 · FY2002 · NS
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTION$311,121
R01 · FY2002 · NS
Graduate Training in the Pharmacological Sciences$150,062
T32 · FY2002 · GM
MODULATION OF KAINATE RECEPTORS$341,146
R01 · FY2001 · NS
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTION$302,117
R01 · FY2001 · NS
MICROARRAY SCANNING SYSTEM$119,545
S10 · FY2001 · RR
Graduate Training in the Pharmacological Sciences$112,032
T32 · FY2001 · GM
MODULATION OF KAINATE RECEPTORS$332,291
R01 · FY2000 · NS
SCIENTIFIC REVIEW AND EVALUATION AWARD$300,000
U09 · FY2000 · GM
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTION$293,368
R01 · FY2000 · NS
GRADUATE TRAINING IN MOLECULAR THERAPEUTICS AND TOXICOL$97,199
T32 · FY2000 · GM